Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jining Medical University maintains a patent portfolio in the Medical Devices & Mechanical Engineering technology area. There is currently 1 pending office action associated with this portfolio. This single action constitutes the entire active workload for the university's patent prosecution efforts, suggesting a very focused approach to its mechanical and medical device filings.
The administrative footprint of the portfolio is very narrow. All prosecution activity is distributed across 1 distinct examiner and 1 distinct art unit. This concentration indicates that the university's innovations are being processed through a single specialized channel within the patent office, which may simplify the coordination of responses and examiner interviews.
DUBOSE, LAUREN is identified as the busiest examiner for this portfolio. This examiner is currently handling 1 pending office action. For practitioners, the prosecution experience is defined by this 1 point of contact, making the specific examination style of DUBOSE, LAUREN the primary factor in determining the current outcomes for the university's patent applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUBOSE, LAUREN | 1 | 60.1% | +43.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18432674 | LAPAROSCOPIC HEPATIC PORTAL OCCLUSION DEVICE | DUBOSE, LAUREN | 40d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18432674 | LAPAROSCOPIC HEPATIC PORTAL OCCLUSION DEVICE | DUBOSE, LAUREN | 40d |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18432674 | LAPAROSCOPIC HEPATIC PORTAL OCCLUSION DEVICE | DUBOSE, LAUREN | 3771 | §103§112 | Non-Final OA | 40d | Pending | Feb 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial